<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Hum Mol Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Hum. Mol. Genet</journal-id>
<journal-id journal-id-type="publisher-id">hmg</journal-id>
<journal-title-group>
<journal-title>Human Molecular Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">0964-6906</issn>
<issn pub-type="epub">1460-2083</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28973543</article-id>
<article-id pub-id-type="pmc">5886307</article-id>
<article-id pub-id-type="doi">10.1093/hmg/ddx345</article-id>
<article-id pub-id-type="publisher-id">ddx345</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Heterozygous loss of <italic>TSC2</italic> alters p53 signaling and human stem cell reprogramming</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Armstrong</surname>
<given-names>Laura C</given-names>
</name>
<xref ref-type="aff" rid="ddx345-aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Westlake</surname>
<given-names>Grant</given-names>
</name>
<xref ref-type="aff" rid="ddx345-aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Snow</surname>
<given-names>John P</given-names>
</name>
<xref ref-type="aff" rid="ddx345-aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cawthon</surname>
<given-names>Bryan</given-names>
</name>
<xref ref-type="aff" rid="ddx345-aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Armour</surname>
<given-names>Eric</given-names>
</name>
<xref ref-type="aff" rid="ddx345-aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bowman</surname>
<given-names>Aaron B</given-names>
</name>
<xref ref-type="aff" rid="ddx345-aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-3730-7351</contrib-id>
<name>
<surname>Ess</surname>
<given-names>Kevin C</given-names>
</name>
<xref ref-type="corresp" rid="ddx345-cor1"></xref>
<!--<email>kevin.ess@vanderbilt.edu</email>-->
<xref ref-type="aff" rid="ddx345-aff1">1</xref>
</contrib>
</contrib-group>
<aff id="ddx345-aff1">
<label>1</label>Division of Pediatric Neurology, Department of Pediatrics, Vanderbilt University Medical Center, D4105 Medical Center North, Nashville, TN 37232, USA</aff>
<author-notes>
<corresp id="ddx345-cor1"><label>*</label>To whom correspondence should be addressed at: Department of Pediatrics, Division of Pediatric Neurology, Vanderbilt University Medical Center, D4105 Medical Center North, 1161 21<sup>st</sup> Avenue South, Nashville, TN 37232, USA. Tel: 615-936-4113; Fax: 615-936-8094; Email: <email>kevin.ess@vanderbilt.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>01</day>
<month>12</month>
<year>2017</year>
</pub-date>
<pub-date iso-8601-date="2017-09-05" pub-type="epub">
<day>05</day>
<month>9</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>12</month>
<year>2018</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>26</volume>
<issue>23</issue>
<fpage>4629</fpage>
<lpage>4641</lpage>
<history>
<date date-type="received">
<day>16</day>
<month>7</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>28</day>
<month>8</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>1</day>
<month>9</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com</copyright-statement>
<copyright-year>2017</copyright-year>
</permissions>
<self-uri xlink:href="ddx345.pdf"></self-uri>
<abstract>
<title>Abstract</title>
<p>Tuberous sclerosis complex (TSC) is a pediatric disorder of dysregulated growth and differentiation caused by loss of function mutations in either the <italic>TSC1</italic> or <italic>TSC2</italic> genes, which regulate mTOR kinase activity. To study aberrations of early development in TSC, we generated induced pluripotent stem cells using dermal fibroblasts obtained from patients with TSC. During validation, we found that stem cells generated from TSC patients had a very high rate of integration of the reprogramming plasmid containing a shRNA against <italic>TP53</italic>. We also found that loss of one allele of <italic>TSC2</italic> in human fibroblasts is sufficient to increase p53 levels and impair stem cell reprogramming. Increased p53 was also observed in <italic>TSC2</italic> heterozygous and homozygous mutant human stem cells, suggesting that the interactions between <italic>TSC2</italic> and p53 are consistent across cell types and gene dosage. These results support important contributions of <italic>TSC2</italic> heterozygous and homozygous mutant cells to the pathogenesis of TSC and the important role of p53 during reprogramming.</p>
</abstract>
<funding-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Institute of Neurological Disorders and Stroke</named-content>
<named-content content-type="funder-identifier">10.13039/100000065</named-content>
</funding-source>
<award-id>RO1 NS078289</award-id>
</award-group>
</funding-group>
<counts>
<page-count count="13"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>